tradingkey.logo

Cibus Inc

CBUS
查看詳細走勢圖
1.710USD
+0.170+11.04%
收盤 12/19, 16:00美東報價延遲15分鐘
89.89M總市值
虧損本益比TTM

Cibus Inc

1.710
+0.170+11.04%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+11.04%

5天

+6.21%

1月

+35.71%

6月

+14.00%

今年開始到現在

-38.49%

1年

-35.35%

查看詳細走勢圖

TradingKey Cibus Inc股票評分

單位: USD 更新時間: 2025-12-19

操作建議

Cibus Inc當前公司基本面數據相對穩定,增長潛力穩定。當前估值合理,在醫療設備與耗材行業排名140/208位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價14.40。中期看,股價處於上升通道。近一個月,市場表現很強,但基本面和技術面綜合得分較低,很強的走勢沒有得到基本面和技術面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Cibus Inc評分

相關信息

行業排名
140 / 208
全市場排名
353 / 4582
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 4 分析師
買入
評級
14.400
目標均價
+805.66%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Cibus Inc亮點

亮點風險
Cibus, Inc. is an agricultural technology company that uses gene-editing technologies to develop plant traits in seeds. Its business is the development of plant traits for some of the agricultural food crops that help address specific productivity, profitability, sustainability, or yield challenges in farming. Its core technology propriety gene editing platform is called the Rapid Trait Development System (RTDS). It is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. It has a pipeline of five productivity traits. It has developed the productivity trait Pod Shatter Reduction (PSR) in Canola and Winter Oilseed Rape (WOSR) strengthens the sheath around the canola seeds. Its advanced productivity traits, Sclerotinia resistance and HT2 in Canola and WOSR, continue to progress and offer white mold disease resistance and broadleaf weed herbicide tolerance.
業績高增長
公司營業收入穩步增長,連續3年增長2614.65%
業績增長期
公司處於發展階段,最新年度總收入4.26M美元
利潤高增長
公司淨利潤處於行業前列,最新年度總收入4.26M美元
估值合理
公司最新PE估值-0.63,處於3年歷史合理位
先鋒集團持倉
明星投資者先鋒集團持倉,最新持倉962.37K股
活躍度降低
近期活躍度降低,過去20天平均換手率-0.12

Cibus Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Cibus Inc簡介

Cibus, Inc. is an agricultural technology company that uses gene-editing technologies to develop plant traits in seeds. Its business is the development of plant traits for some of the agricultural food crops that help address specific productivity, profitability, sustainability, or yield challenges in farming. Its core technology propriety gene editing platform is called the Rapid Trait Development System (RTDS). It is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. It has a pipeline of five productivity traits. It has developed the productivity trait Pod Shatter Reduction (PSR) in Canola and Winter Oilseed Rape (WOSR) strengthens the sheath around the canola seeds. Its advanced productivity traits, Sclerotinia resistance and HT2 in Canola and WOSR, continue to progress and offer white mold disease resistance and broadleaf weed herbicide tolerance.
公司代碼CBUS
公司Cibus Inc
CEOBeetham (Peter Ronald)
網址https://www.cibus.com/

常見問題

Cibus Inc(CBUS)的當前股價是多少?

Cibus Inc(CBUS)的當前股價是 1.710。

Cibus Inc 的股票代碼是什麼?

Cibus Inc的股票代碼是CBUS。

Cibus Inc股票的52週最高點是多少?

Cibus Inc股票的52週最高點是3.500。

Cibus Inc股票的52週最低點是多少?

Cibus Inc股票的52週最低點是1.090。

Cibus Inc的市值是多少?

Cibus Inc的市值是89.89M。

Cibus Inc的淨利潤是多少?

Cibus Inc的淨利潤為-251.39M。

現在Cibus Inc(CBUS)的股票是買入、持有還是賣出?

根據分析師評級,Cibus Inc(CBUS)的總體評級為買入,目標價格為14.400。

Cibus Inc(CBUS)股票的每股收益(EPS TTM)是多少

Cibus Inc(CBUS)股票的每股收益(EPS TTM)是-2.713。
KeyAI